Alda Tam, MD, presents the case of a 60-year-old man with mesothelioma.
Radiation lobectomy is an evolving technique that offers an alternative to portal vein embolization for patients who are not surgical candidates as a result of insufficient future liver remnant. In this interview, Robert Lewandowski, MD, an interventional radiologist and Director of Interventional… Read More
Dan Brown, MD, shows case examples demonstrating timing of Y-90 therapy and personalizing therapy to the patient's biology.
Current Therapy for Neuroendocrine Disease: When is Lutetium-177 Peptide Receptor Radionuclide Therapy Indicated?
Because overall survival of patients with metastatic neuroendocrine tumors (NET) is usually longer than other types of metastatic cancers, deciding which treatment can best control the disease over a long period of time without causing long-term side effects that might affect survival or quality of… Read More
In this video, Sean M. Tutton, MD, FSIR discusses the 5 P’s of MSK interventions and the importance of remembering the mnemonic device “Prior Planning Prevents Poor Performance.”
Ablation and stereotactic body radiation therapy (SBRT) are both effective treatments for patients with hepatocellular carcinoma (HCC), especially those in early stages of the disease. Siddharth A. Padia, MD explains what interventional radiologists need to know when deciding between ablation and… Read More
In this video, Matthew Callstrom, MD, PhD discusses the risk of collecting system injury with microwave ablation and how central renal tumors can be effectively treated.
When talking to hospitals and oncologists about the benefits of having a full-time interventional radiology (IR) faculty, it is important to highlight the work related value units (wRVUs) that can be brought in from a clinical prospective, according to a presentation from Sarah White, MD, MS, FSIR… Read More